The authors defined “suboptimal” pts as those with PS ECOG = 2, weight loss 10-25 % and/or age ≥70 years. This population is usually underrepresented in AGC clinical trials. Although miniDOX’s toxicity (mainly PE) has been important, its activity has been promising in “suboptimal” pts with AGC, and this combination should be further investigated in this setting.

READ FULL ARTICLE Curated publisher From Mdlinx